Aeglea BioTherapeutics
peace phase trial mobility assessed by and | Aeglea BioTherapeutics
Company
Deck Type
Sector
Industry
Deck date
April 2023
Slide
18 of 37
Similar slides by Aeglea BioTherapeutics
See diffirences between slides (animation)
Investor Presentation
May 2023
peace phase trial mobility assessed by and | Aeglea BioTherapeutics
Investor Presentation
March 2023
peace phase trial mobility assessed by and | Aeglea BioTherapeutics
Investor Presentation
February 2022
peace mobility assessed by and | Aeglea BioTherapeutics
Results
December 2021
mobility assessment by minute walk test | Aeglea BioTherapeutics
Related slides by other companies
Myovant Sciences
Results
August 2022
achieved sustained reductions in non menstrual pelvic pain scores scores | Myovant Sciences
Myovant Sciences
Results
August 2022
change from in lumbar spine at month in pooled data from spirit and studies | Myovant Sciences
ATAI
Investor Day
January 2022
change from in the overall composite score | ATAI
argenx SE
Results
December 2022
resulted in targeted reduction of levels | argenx SE
Other recent decks by Aeglea BioTherapeutics
See all presentations (14 decks)
Investor Presentation
October 2023
Investor Presentation
October 2023
Investor Presentation
September 2023
Investor Presentation
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io